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Activation-induced cytidine deaminase (AID) is essential for the physiological alterations in immunoglobulin genes that generate antibody memory: class-switch recombination (CSR) and somatic hypermutation 1, 2 . Somatic hypermutation introduces nontemplated point mutations at a high frequency in the variable (V) regions of antibody genes, which, in conjunction with cellular selection mechanisms, give rise to high-affinity antibodies. CSR is region-specific DNA recombination that occurs between two switch (S) regions located 5′ to each heavy-chain constant-region (C H ) gene. This recombination juxtaposes a downstream C H gene with the V-region gene by excising the intervening C H genes. CSR results in immunoglobulin class switching without a change in antigen specificity 3, 4 .
AID is responsible for DNA cleavage in both the V and S regions [5] [6] [7] [8] . As DNA cleavage by AID can be deleterious to the genome, it is tightly regulated; almost no expression is observed in non-B cells or even in B cells unless they have been activated by appropriate stimuli, such as lipopolysaccharide (LPS), the ligand for the costimulatory molecule CD40 (CD40L; A000536), or certain cytokines, including interleukin 4 (IL-4; A001262), transforming growth factor-β (TGF-β; A002271) and interferon-γ (IFN-γ) 9, 10 . Consequently, the transcriptional regulatory system of Aicda (the gene that encodes AID) should include both lineage-specific and stimulus-specific response elements.
Complicating the picture outlined above is the fact that AID seems to target not only immunoglobulin genes but also several oncogenes that are frequently mutated or translocated to immunoglobulin loci in B cell malignancies 11 . Studies of AID-deficient mice suggest that AID may be involved in the pathogenesis of B cell malignancy [12] [13] [14] [15] [16] .
Aberrant AID expression in human B cell lymphomas is also speculated to correlate with the degree of malignancy 11, 17 . Notably, infection with certain viruses or bacteria that are potentially tumorigenic can induce AID expression in B cells and non-B cells [18] [19] [20] . Such ectopic expression of AID may contribute to tumorigenesis when AID expression persists during chronic infection [20] [21] [22] . In support of that idea, systemic overexpression of AID in transgenic animals leads to tumor development in various organs [22] [23] [24] .
Several studies have addressed the mechanism of the transcriptional regulation of Aicda. A putative promoter region has been identified immediately upstream of the transcription start site (TSS), but this promoter is not lymphocyte specific 25 . Two tandem E-boxes, recognized by E proteins such as E2A, located in the first intron, have been proposed to be important for the induction of AID in B cells 26 . The transcription factor Pax5 (A000403) may have a role, together with E proteins, in the B lineage-specific control of AID expression 27 . However, the location of the functional Pax5 motif is controversial 25, 27 . In addition, the functional contributions of proposed putative binding sites for the transcription factors STAT6 (A002236) and NF-κB (A001645), located upstream of the Aicda promoter, are not yet clear 28 . Finally, most previous studies have used cell lines whose AID expression is constitutive or primary B cells fully stimulated by mitogens. Additional information will require detailed and thorough studies of the regulatory elements of Aicda in stable cell lines in which AID expression is inducible.
In this study, we did an extensive analysis with luciferase reporter assays to determine the functional regulatory elements of the Aicda The Aicda promoter is not CIT responsive To study the cis-regulatory elements of Aicda by the luciferase reporter assay, we used CH12F3-2 cells, in which AID expression is barely detectable and is considerably upregulated by stimulation with CIT, which results in efficient CSR to immunoglobulin A 9 . First we generated plasmids containing serial 5′ deletions of region 1 ligated to a firefly luciferase-encoding region to determine whether region 1 contributes to the induction of AID by CIT. This region contains several elements that have been proposed or demonstrated to be involved in Aicda regulation, including an Sp-binding motif 25 originally reported as a putative Pax5 site 27 , STAT6 and NF-κB sites 28 , and HoxC4-Oct motifs 31 . We transiently transfected the constructs into CH12F3-2 cells and measured the luciferase activity of each sample. We found that all the constructs tested had approximately four-to eightfold more luciferase activity than did pGL3, the promoterless luciferase vector. We also found weak positive and negative effects on luciferase activity by the Sp motif and the GA-rich sequence whose binding factor is unknown, respectively (Fig. 1b) . Unexpectedly, however, none of these constructs showed any response to the CIT stimulation. The HoxC4-Oct element has been shown to be involved in AID expression in experiments with Hoxc4 −/− B cells 31 , but this fragment alone did not respond substantially to CIT. The HoxC4-Oct element may be involved in the basal expression of AID.
Therefore, we extended our analysis to the other conserved regions to identify CIT-responsive enhancer elements. We also sought stronger B cell-specific enhancer elements, because Sp1 and Sp3 are general transcription factors and the activity of the HoxC4-Oct motif was minimal, although it is lymphoid specific 31, 32 . As the 100-base pair fragment immediately upstream of TSS, containing the Sp and HoxC4-Oct motifs, still activated transcription fivefold, to an amount almost equivalent to that induced by the entire region 1, we used this fragment as the minimal promoter.
Regulation of the Aicda promoter by regions 2 and 4
To delineate the roles of the conserved regions in the regulation of AID expression, we constructed reporter vectors containing region 1 in combination with region 2, 3 or 4. The addition of region 2 to region 1 resulted in luciferase activity that was 50% lower, and this construct did not respond to CIT stimulation (Fig. 1c) . In contrast, a construct containing both region 1 and region 4 induced enhanced luciferase activity in response to CIT stimulation, and its basal activity was also slightly higher than that of the region 1-only construct, which suggests that region 4 contains DNA elements responsive to IL-4, TGF-β and/or CD40L. 
A r t i c l e s
In contrast, the addition of region 3 did not result in any substantial change in either the basal or CIT-induced Aicda promoter activity, in contrast to a published report 30 (Fig. 1c) . Serial deletion of region 3 fragments did not demonstrate any substantial effects on the luciferase activity driven by region 1 either (data not shown). Together our data indicated that the basal expression of AID in CH12F3-2 cells was regulated negatively by region 2 and positively by region 4, whereas no enhancer activity was detectable in region 3 by the luciferase assay. In addition, region 4 was responsible mainly for the upregulation of Aicda in response to CIT stimulation.
Region 2 confers B cell specificity
To delineate the regulatory elements in region 2, we made serial deletions of region 2 and ligated the fragments downstream of the luciferase reporter construct driven by the minimal Aicda promoter (positions −101 to +1; Fig. 2a,b) . CIT stimulation did not cause a substantial increase in the luciferase activity of CH12F3-2 cells expressing any of these constructs. This result supported the idea that the CITresponsive element is located outside region 2.
Further study of region 2 to find B cell-specific regulators showed that a deletion of the 3′ sequence (positions +1709 to +1789) resulted in luciferase activity six times greater than that induced by full-length region 2 (Fig. 2a, line 4) , which suggested there were negative regulatory elements in the deleted sequence. Further serial deletion of the two E-boxes resulted in diminished activity almost equal to that of the minimal promoter (Fig. 2a , lines 5 and 6), in agreement with a published report on the enhancer function of these E-boxes 26 . When the Pax5 element was also deleted, the luciferase activity dropped even lower (Fig. 2a, line 7) .
To confirm the positive roles of the Pax5 motif and E-boxes, we made constructs with only these motifs because the suppressive effect of the adjacent sequences masked their activity. The fragment containing only the Pax5 site and the two E-boxes enhanced the luciferase activity of the minimal promoter about threefold (Fig. 2c, line 4) . Mutating any one of the three motifs obviously impaired the enhancer activity ( (Fig. 2a, line 9 , and b, line 7), which suggested the presence of other negative regulatory motifs in this region. We excluded the possibility of a contribution from the Mzf1-1 and Cp2-1 motifs by mutagenesis experiments, as we observed no substantial differences relative to results obtained with the intact region ( Supplementary Fig. 2 ). Although the suppressor activity of a 350-base pair CT-rich sequence from position +874 to position +1221 was obvious only with the 5′-deletion construct (Fig. 2a,b) , a similar sequence has a reported suppressor function in another gene, Cyp1a1 (encoding a cytochrome P450 protein), in epidermal keratinocytes 33 . Notably, the activity of the B cell-specific enhancers (the Pax5 site and E-boxes) was not sufficient to counter the effect of the suppressive elements, including c-Myb-1, c-Myb-2, Nkx2.5, E2f and the CT-rich sequence of region 2 ( Figs. 1c and 2a,b) .
Suppressor elements in region 2 counteract enhancers
We also examined the interaction between regions 2 and 4. Region 2 suppressed the enhancer activity of region 4 regardless of CIT stimulation (Fig. 2d, line 4) . As region 4 considerably amplified the luciferase activity, we were able to confirm the suppressor activities observed in the deletion experiments. Deletion of the CT-rich sequence together with the inactive NF-κB-3 motif led to a slightly higher luciferase activity (Fig. 2d, line 5 ). Additional point mutations in one of the three motifs in this region, c-Myb-1, E2f or c-Myb-2 (overlapping the Nkx2.5 site), diminished the suppression activity (Fig. 2d , lines 6-8). The combined disruption of all these motifs along with the CT-rich region almost completely abolished the suppressor activity of region 2 ( Fig. 2d, line 9 ). Although the possibility of involvement of Nkx2.5 cannot be formally excluded, a knockdown experiment with a small interfering RNA oligonucleotide specific for c-Myb increased the luciferase activity, but a small interfering RNA oligonucleotides specific for Nkx2.5 did not ( Supplementary  Figs. 3 and 4) . Together these results indicate that the binding motifs in region 2 for c-Myb and E2f, and the CT-rich sequence, function independently as suppressor elements to counteract the positive elements in region 2 and region 4.
Elements responsible for CIT stimulation in region 4
IL-4, TGF-β and CD40L induce AID expression independently and additively in CH12F3-2 cells 9 . To confirm that region 4 contains independent response elements for IL-4, TGF-β or CD40L, we examined each stimulus separately. IL-4, TGF-β, and CD40L each individually upregulated the luciferase activity of the construct carrying region 4 (Fig. 3a) . Combining the three stimuli resulted in the highest activity, and the increment seemed to be additive.
To identify the functional elements in region 4, we generated a series of deletion constructs (Fig. 3b,c) . The inductive response to CIT stimulation was decreased considerably by deletion of the region containing the element for STAT6-1 (Fig. 3b line 5 ), STAT6-2 (Fig. 3c, line 4) , NF-κB-2 (Fig. 3b, line 6 ), Smad3/4 (Fig. 3c, line  6 ), C/EBP-1 (Fig. 3b, line 7) or C/EBP-2 (Fig. 3c, line 7) . Among these elements, NF-κB-2 and the two tandem C/EBP motifs seemed to provide a considerable contribution to the basal activity as well. In contrast, the deletion of the region containing the element for NF-κB-1 (Fig. 3b, line 4) or C/EBP-3 (Fig. 3c, line 5 ) had no effect on luciferase activity. 
A r t i c l e s
The mutagenesis experiments reported above confirmed the involvement of the region 4 elements. Mutation of either or both of the STAT6-binding sequences resulted in much lower induction of luciferase activity by IL-4 alone as well as by CIT (Fig. 4a, lines 4-7) , which indicated that both sites are response elements for the IL-4 signal. STAT6 knockdown almost completely blocked the luciferase induction by IL-4 stimulation ( Fig.4b and Supplementary Fig. 5 ). We conclude that the IL-4 signal activates the Aicda promoter through the STAT6-1-and STAT6-2-binding sites on region 4.
Destruction of the NF-κB-2 motif considerably impaired the response to both CD40L alone and to CIT (Fig. 4c, line 4) . The NF-κB-specific inhibitor sulfasalazine almost completely suppressed the luciferase induction by CD40L through region 4 ( Fig. 4d and Supplementary  Fig. 6 ). The inactivation of NF-κB also diminished the basal activity.
When the Smad3/4 site was mutated, the TGF-β response and basal activity were suppressed (Fig. 4e, line 4) . Furthermore, in agreement with the results of the deletion experiment, the two C/EBP-binding sites were required for the response to both TGF-β alone and to CIT (Fig. 4f, lines 4 and 5). Thus, the pair of C/EBP sites was required for the region 4 response to all three CIT components (IL-4, CD40L and TGF-β). However, the C/EBP sites alone did not respond to CIT stimulation (Fig. 4g) , which indicated that the pair of C/EBP sites was required but not sufficient.
Finally, we examined whether the CIT response was dependent on the B cell-specific enhancers (Pax5-binding site and E-boxes) of region 2 when the repressor elements coexisted. Deletion of the Pax5-binding site and E-boxes from the reporter construct containing regions 2 and 4 still showed induction by CIT, although the luciferase activity was diminished to about 35% (Fig. 5a, lines 4 and 5) . These results indicated that the B cell-specific enhancers were not absolutely essential for the CIT response through region 4, at least in our luciferase system.
We tested the same constructs used above in two non-B cell lines: 2B4.11 T cells and NIH3T3 cells (fibroblast cell line). The basal luciferase activity in CH12F3-2 cells by the region 4 reporter alone was approximately twice that in the non-B cells (Fig. 5b, line 3) , which indicated that CH12F3-2 cells express more intrinsic factors for AID expression than do non-B cells. The addition of region 2 repressed the basal activity not only in the B cells but also in the other lineages (Fig. 5b, line 4) , which indicated that the region 2 silencers were active in non-B cells as well as B cells. Notably, deletion of the Pax5-binding site and E-boxes diminished the luciferase activity only in B cells (Fig. 5b, line 5) .
Involvement of candidate transcription factors
To examine in vivo binding of the transcription factors to the candidate regulatory elements, we did chromatin-immunoprecipitation (ChIP) assays of region 2 or 4 (Fig. 6a) . We found that 12 h of cultivation with CIT significantly induced specific binding of NF-κB, C/EBPβ, STAT6 and Smad4 to region 4 in CH12F3-2 cells (Fig. 6b) . We tried to assess c-Myb and some of the E2f proteins (E2f-1, E2f-4 and E2f-5) without success, partly because of the absence of high-quality antibodies (data not shown). C/EBPβ and STAT6 also bound to region 4 in spleen B cells activated by LPS and IL-4 (Fig. 6c) . Binding of Pax5 and E-proteins to region 2 has already been demonstrated 26, 27 .
To confirm involvement of the transcription factors noted above in Aicda regulation, we examined their expression profiles in stimulated spleen B cells (Fig. 7) . Expression of mRNA for STAT6, NF-κB, Smads, C/EBPs, Pax5, E2a, cMyb, E2f-2 and E2f-4 was rapidly induced by stimuli of LPS, IL-4 and TGF-β, decreased by 12 h and was maintained thereafter. Expression of E2f-7 and E2f-8, which can repress by binding to the E2f motif 34 , increased 20 h after stimulation, in parallel with AID expression. We also compared the expression of these factors in naive and germinal center B cells. Most of the activators were already well expressed in naive cells (Supplementary Fig. 7 ), which suggested activation of their function by the protein modification after stimulation. Expression of the repressive E2f proteins E2f-5, E2f-7 and E2f-8 and c-Myb was higher in germinal center B cells. As the suppressive elements were functional in CIT-stimulated CH12F3-2 cells, the higher expression of candidate repressor proteins (E2f and c-Myb) in activated B cells may have been a feedback response to prevent overexpression of AID (Supplementary Fig. 8 ).
DISCUSSION
In the present study we have identified three functionally important regions in the 10-kb region upstream of Aicda and within this gene. Region 1 serves as the basic promoter and contains positive elements (Sp-binding sites and a HoxC4-Oct motif ) and a weak negative element (the GA-rich sequences). Region 2, located in the first intron of Aicda, also contains both positive elements (a Pax5-binding site and E-boxes) and negative elements (c-Myb-and E2f-binding sites). On balance, region 2 functions as a negative regulator when combined with region 1. Here we have shown that the Pax5-binding site and E-boxes in region 2 contribute to the restriction of AID expression to the B cell lineage. Region 4 contains the functional binding sites for NF-κB, STAT6 and Smad3/4, which are response elements for CD40L, IL-4 and TGF-β, respectively. A tandem pair of C/EBP-binding sites is required for each of these elements to respond to CIT stimulation. A similar requirement for a tandem pair of C/EBP elements has been reported for the gene encoding the common β-chain of the receptors for IL-3, IL-5 and granulocyte-macrophage colony-stimulating factor 35 . Because AID promotes genome-wide damage and leads tumorigenesis, the promoter activity should be finely regulated. In fact, AID expression is restricted almost entirely to activated B cells. How could such restricted expression be achieved by the elements we found in this study? Perhaps the key is the negative elements in region 2. These counteract positive signals mediated from cytokine or Toll-like receptors, which are widely expressed. They also work against B cell-specific enhancers whose binding proteins are functional even in resting B cells and thus would confer active transcription only in activated B cells.
The transcription factor c-Myb often functions as a transcription activator, but it also represses many genes, including Cd4, Nras and Erbb2 (refs. 36-38) . Notably, the repressive c-Myb-binding site of the Cd4, whose expression is tightly regulated during T cell development, is also located in the first intron 38 . Some E2f proteins, such as E2f-4, E2f-5 and E2f-6, can reversibly repress a promoter in conjunction with other corepressors 39 . E2f proteins can also induce stable repression by recruiting the polycomb complex 40 . Such a mechanism might be involved in the complete silencing of Aicda in nonlymphoid cells. Notably, we found more E2f-7 and E2f-8 in in vitro-activated and germinal center B cells. E2f-7 and E2f-8 counteract activating E2f proteins 34 . Given the finding that activating E2f proteins were also upregulated in germinal center cells, they might bind to region 2 in certain conditions, and E2f-7 and E2f-8 would counteract them. We did not detect any enhancer activity at the E2f site in region 2, but this could have been due to the expression pattern of E2f proteins in CH12F3-2 cells, which have high expression of potentially repressive E2f proteins, such as E2f-4, E2f-5 and E2f-6 (data not shown). It still remains unsolved which E2f proteins are actually responsible for the repressive function in region 2.
We found discrepancies between our results and published studies of AID regulation. An active Pax5-binding site in region 1 has been proposed, but another group subsequently concluded the site is in fact an Sp-binding site 25, 27 . Our mutagenesis experiments indicated Pax5 involvement, but the responsive site was the one in region 2. Another discrepancy was our inability to detect enhancer activity in region 3, which is reported to be required for AID expression in the bacterial artificial chromosome-transgenic mouse 30 . Region 3 might contain a positive regulator that works only in the context of chromatin.
Our study has suggested that the region 4 is essential for the AID response in B cells to the environmental stimulation delivered by T cells, dendritic cells and other cytokine-producing cells. Immature B cells are reported to have low expression of AID by signaling through Toll-like receptors 41, 42 . Furthermore, it has been shown that even gastric epithelial cells and hepatocytes can express AID after infection 20, 21 . The mechanism for this AID induction is not clear from our studies in B lineage cells. The NF-κB site in region 4 could be involved in the AID-induction signal through Toll-like receptors or other pathways in response to bacterial or viral infection 43 . The binding of negative regulators to the elements in region 2 should counteract NF-κB in normal conditions, to suppress Aicda and retain genomic stability. We were unable to identify a candidate response element for IFN-γ (STAT1-binding site). Because IFN-γ can activate the NF-κB pathway 44 , and also because STAT1 can form a heterodimer with other STAT proteins, including STAT6 (ref. 45) , the regulation of Aicda by IFN-γ would not need an obvious STAT1-binding motif. We could not test this hypothesis because CH12F3-2 cells do not respond to IFN-γ. We were unable to test the effect of B cell antigen receptor signaling in CH12F3-2 cells because it affects CSR only marginally (data not shown).
Our present assay system has obvious limitations for recapitulating the complete repression of Aicda by silencers. The luciferase assay depends on transient transfection with a large dose of plasmid DNA whose regulation might be different from that of the endogenous Aicda gene. However, the results of ChIP analyses and the expression profiles of candidate transcription factors in CH12F3-2 and spleen B cells are in general agreement with the conclusion derived from the luciferase assay. The next step to confirm our findings will be in vivo mutagenesis with either gene targeting or bacterial artificial chromosome-transgenic strategies. In summary, our findings have emphasized that two separate regions, region 2 and region 4, carry out physiologically distinct regulatory functions in Aicda expression in which derepression from the effects of silencers by B lineage-specific and stimulation-responsive enhancers is critical. The evolution of such a sophisticated regulatory system for the Aicda locus seems reasonable, even necessary, as its product is essential to antibody memory but has the potential to induce genomic instability.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
